REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
10.38
+1.73 (20.00%)
At close: Mar 9, 2026, 4:00 PM EDT
9.98
-0.40 (-3.85%)
After-hours: Mar 9, 2026, 7:57 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $535.74 million as of March 9, 2026. Its market cap has increased by 46.90% in one year.
Market Cap
535.74M
Enterprise Value
555.41M
1-Year Change
46.90%
Ranking
Category
Stock Price
$10.38
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $535.74M, a decrease of -28.50%. That is a compound annual growth rate of -3.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 446.50M | -38.75% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 466.36M |
| Kyverna Therapeutics | 462.75M |
| Altimmune | 460.45M |
| Century Therapeutics | 459.90M |
| Entrada Therapeutics | 452.88M |
| Lineage Cell Therapeutics | 448.31M |
| Assembly Biosciences | 447.15M |
| vTv Therapeutics | 437.04M |